Business Description
Bayer AG
ISIN : ARDEUT112414
Share Class Description:
BUE:BAYN: CedearTotal Employee Number:
90,885Compare
Compare
Traded in other countries / regions
BAYN.Germany0P6S.UKBAYRY.USA1BAYN.ItalyBAYN.AustriaBAYN.RomaniaBAYER.HungaryBAYN.BulgariaBAY.PolandBAYN.SwitzerlandBAYNN.MexicoBAYN.Argentina Description
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 1.26 | |||||
Debt-to-EBITDA | 12.37 | |||||
Interest Coverage | 3.58 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 0.84 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.5 | |||||
3-Year EBITDA Growth Rate | -47.2 | |||||
3-Year EPS without NRI Growth Rate | -13.2 | |||||
3-Year FCF Growth Rate | -6 | |||||
3-Year Book Growth Rate | -12.5 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 1.98 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.06 | |||||
Quick Ratio | 0.7 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 243.86 | |||||
Days Sales Outstanding | 93.76 | |||||
Days Payable | 129.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | -62 | |||||
Shareholder Yield % | 8.31 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 59.32 | |||||
Operating Margin % | 16.23 | |||||
Net Margin % | -4.77 | |||||
EBITDA Margin % | 6.51 | |||||
FCF Margin % | 6.16 | |||||
OCF Margin % | 11.76 | |||||
ROE % | -7.32 | |||||
ROA % | -2.03 | |||||
ROIC % | 7.69 | |||||
3-Year ROIIC % | 2.35 | |||||
ROC (Joel Greenblatt) % | 0.64 | |||||
ROCE % | 0.11 | |||||
Years of Profitability over Past 10-Year | 6 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 0.51 | |||||
Shiller PE Ratio | 59.39 | |||||
Price-to-Owner-Earnings | 20.91 | |||||
PS Ratio | 1.16 | |||||
PB Ratio | 1.82 | |||||
Price-to-Free-Cash-Flow | 19.84 | |||||
Price-to-Operating-Cash-Flow | 10.18 | |||||
EV-to-EBIT | 1001.68 | |||||
EV-to-Forward-EBIT | 51.53 | |||||
EV-to-EBITDA | 27.54 | |||||
EV-to-Forward-EBITDA | 8.35 | |||||
EV-to-Revenue | 1.79 | |||||
EV-to-Forward-Revenue | 1.86 | |||||
EV-to-FCF | 30.72 | |||||
Price-to-GF-Value | 1.95 | |||||
Price-to-Projected-FCF | 1.06 | |||||
Price-to-Median-PS-Value | 0.95 | |||||
Earnings Yield (Greenblatt) % | 0.1 | |||||
FCF Yield % | 5.04 | |||||
Forward Rate of Return (Yacktman) % | 7.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bayer AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ARS) | 71,211,907.45 | ||
| EPS (TTM) (ARS) | -3786.237 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -59.39 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 1.57 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (ARS) | - | ||
| 20-Day SMA (ARS) | 3800 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (ARS) | 3800 - 3800 | ||
| Shares Outstanding (Mil) | 982.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bayer AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bayer AG Stock Events
| Event | Date | Price (ARS) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-03 06:30 | In 122 days | ||
| Third quarter earnings results for 2026 | 2026-11-03 01:00 | In 122 days | ||
| Bayer Crop Science Investor Event | 2026-09-02 | In 59 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 05:30 | In 31 days | ||
| Second quarter earnings results for 2026 | 2026-08-04 | In 30 days | ||
| Deutsche Bank European Champions Conference | 2026-05-27 01:31 | 3,800.00 (+0.00%) | ||
| Guidance call for 2026 | 2026-05-14 10:15 | 3,800.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-12 14:00 | 3,800.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-12 | 3,800.00 (+0.00%) | ||
| USD 0.042760 Cash Dividend | 2026-04-27 | 3,800.00 (+0.00%) |
Show
Entries
Bayer AG Frequently Asked Questions
What is Bayer AG(BUE:BAYN)'s stock price today?
The current price of BUE:BAYN is ARS3800.00. The 52 week high of BUE:BAYN is ARS3800.00 and 52 week low is ARS3800.00.
When is next earnings date of Bayer AG(BUE:BAYN)?
The next earnings date of Bayer AG(BUE:BAYN) is 2026-08-04.
Does Bayer AG(BUE:BAYN) pay dividends? If so, how much?
Bayer AG(BUE:BAYN) does not pay dividend.
Press Release
Articles on Bayer AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers